Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Mount Sinai Hospital
1468 Madison AvenueAnnenberg Building, 4th Floor
New York, New York, United States
Phone Web
In addition to dedicated treatment programs in hemophilia, sickle cell disease, and thrombophilia, our physicians provide care to children with anemia secondary to hemoglobinopathy, red cell membrane or enzyme disorders, aplastic anemia (including Fanconi’s anemia), thrombocytopenia (also known as ITP), neutropenia, polycythemia, and thrombocytosis.
Hematological conditions treated here include:
-Sickle cell disease
-Hemoglobinopathies
-Anemia
-Congenital and acquired thrombocytopenia including ITP
-Bleeding and clotting disorders
Our pediatric hematologists have been delivering state-of-the-art care to all patients with sickle cell disease for several decades. Basic research at Mount Sinai has included gene therapy for hemoglobinopathy, studies on cell interactions that lead to the excessive adhesion of red cells and enhancement of fetal hemoglobin to minimize the symptoms of sickle cell disease. The Sickle Cell Program here is a comprehensive program designed to provide holistic care. Patients have access to social workers, genetic counselors, cardiologists, pulmonologists, neurologists, and psychologists. Together with the experienced Pediatric Intensive Care Unit staff, the hospital treats the most life threatening complications such as stroke and acute chest syndrome. The blood bank provides accessibility to hemopheresis for emergencies.
+myBinderRelated Content
-
Barbara Speller Brown, DNP, MSNBarbara Speller-Brown, DNP, MSN, PNP-BC,...
-
GlycoMimetics Announces Pricing of Public Offering of Common StockGlycoMimetics, Inc. (NASDAQ: GLYC), a cl...
-
Allan F. Platt, MMSc, PA-C, DFAAPAAllan Platt has served as co-founder and...
-
Pediatric Residents’ Perceived Barriers to Opioid Use in Sickle Cell Disease Pain ManagementObjective: Current guidelines recommend...
-
Boston Children’s Hospital receives grant for sickle cell disease researchThe Bill and Melinda Gates Foundation aw...
-
The first two years of life in sickle cell anemia infants: A results of a comprehensive longitudinal studyInfancy is a critical time during which ...
-
Webinar Series: Sickle Cell Science: Path to Progress – Serving the Sickle Cell Disease Community Here and Abr...To commemorate Sickle Cell Awareness Mon...
